Business Standard

Medtronic beats Q3 profit estimates on strong demand for ventilators

The world's largest standalone medical device maker said it would not provide a forecast for 2021 due to uncertainties surrounding the Covid-19 pandemic

Medtronic beats Q3 profit estimates on strong demand for ventilators
Premium

Excluding items, Medtronic earned $1.29 per share, beating analysts' expectations of $1.15 per share

Reuters
Medtronic Plc beat estimates for third-quarter profit on Tuesday, boosted by strong demand for its ventilators and robots used in surgeries.
 
The world's largest standalone medical device maker said it would not provide a forecast for 2021 due to uncertainties surrounding the Covid-19 pandemic.
 
As vaccination rollouts take place across the United States, sales of medical device makers are expected to bounce back to normal. Medtronic in November had said the vaccines would help the company reach pre-pandemic growth levels by the fourth quarter.
 
Medtronic's minimally invasive therapies business, which makes surgical instruments to treat hernias, kidney diseases and ventilators,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in